ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Lumos Pharma, Inc. clinical trials

Also known as NewLink Genetics.

Part of Double Point Ventures LLC, which holds 100% as of 2024-12-12. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 42 studies whose lead sponsor is Lumos Pharma, Inc. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Lumos Pharma with Novo Nordisk and Eli Lilly →

Pipeline: 2 programs

Each counted once: 2 with a study Lumos Pharma, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Lumos Pharma, Inc.’s own registered studies; Lumos Pharma, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Lumos Pharma, Inc.’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 42 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now512%Not yet recruiting 3 · Recruiting 1 · Enrolling by invitation 1
  • Under way, not recruiting12%
  • Completed2150%
  • Stopped early1536%Terminated 14 · Withdrawn 1

Phase

  • Phase 227
  • Phase 120
  • Phase 35
  • Early Phase 11

Where

  • United States37
  • Australia3
  • Poland3
  • Chile2
  • New Zealand2
  • Ukraine2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 615
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 6 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lumos Pharma, Inc.

  • NewLink Genetics Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    34 studies
  • Lumos Pharma
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies

Focus areas

Conditions Lumos Pharma, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 42 of 42.